Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 7.66
(-0.39%)
CNY 7.66
(-0.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -711.3 Million CNY | -93.91% |
| 2022 | -366.83 Million CNY | 19.31% |
| 2021 | -454.62 Million CNY | 34.87% |
| 2020 | -698.06 Million CNY | -135.37% |
| 2019 | -296.58 Million CNY | -43.95% |
| 2018 | -206.03 Million CNY | -15.81% |
| 2017 | -177.9 Million CNY | -263.9% |
| 2016 | -48.88 Million CNY | -1370.27% |
| 2015 | -3.32 Million CNY | -104.98% |
| 2014 | 66.81 Million CNY | 6.69% |
| 2013 | 62.62 Million CNY | 35.46% |
| 2012 | 46.23 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -654.98 Million CNY | 4.58% |
| 2024 Q3 | -603.24 Million CNY | -10.42% |
| 2024 Q1 | -686.45 Million CNY | 3.49% |
| 2023 Q2 | -837.22 Million CNY | -9.48% |
| 2023 Q1 | -764.7 Million CNY | -108.46% |
| 2023 Q3 | -711.91 Million CNY | 14.97% |
| 2023 FY | -711.3 Million CNY | -93.91% |
| 2023 Q4 | -711.3 Million CNY | 0.09% |
| 2022 Q4 | -366.83 Million CNY | -15.67% |
| 2022 Q3 | -317.13 Million CNY | 1.38% |
| 2022 FY | -366.83 Million CNY | 19.31% |
| 2022 Q1 | -347.33 Million CNY | 23.6% |
| 2022 Q2 | -321.55 Million CNY | 7.42% |
| 2021 FY | -454.62 Million CNY | 34.87% |
| 2021 Q3 | -423.11 Million CNY | 16.43% |
| 2021 Q1 | -416.99 Million CNY | 40.26% |
| 2021 Q2 | -506.28 Million CNY | -21.41% |
| 2021 Q4 | -454.62 Million CNY | -7.45% |
| 2020 Q1 | -257.82 Million CNY | 13.07% |
| 2020 FY | -698.06 Million CNY | -135.37% |
| 2020 Q2 | -308.96 Million CNY | -19.84% |
| 2020 Q3 | -294.85 Million CNY | 4.57% |
| 2020 Q4 | -698.06 Million CNY | -136.75% |
| 2019 Q3 | -253.54 Million CNY | -14.25% |
| 2019 FY | -296.58 Million CNY | -43.95% |
| 2019 Q1 | -216.52 Million CNY | -5.09% |
| 2019 Q4 | -296.58 Million CNY | -16.98% |
| 2019 Q2 | -221.91 Million CNY | -2.49% |
| 2018 Q2 | -206.83 Million CNY | 5.57% |
| 2018 FY | -206.03 Million CNY | -15.81% |
| 2018 Q1 | -219.03 Million CNY | 8.89% |
| 2018 Q4 | -206.03 Million CNY | 3.3% |
| 2018 Q3 | -213.07 Million CNY | -3.02% |
| 2017 Q4 | -240.38 Million CNY | -5.31% |
| 2017 FY | -177.9 Million CNY | -263.9% |
| 2017 Q1 | -42.3 Million CNY | 13.46% |
| 2017 Q2 | -310.96 Million CNY | -634.97% |
| 2017 Q3 | -228.27 Million CNY | 26.59% |
| 2016 Q1 | 58.2 Million CNY | 0.0% |
| 2016 FY | -48.88 Million CNY | -1370.27% |
| 2016 Q4 | -48.88 Million CNY | 0.0% |
| 2015 Q1 | 23.98 Million CNY | 0.0% |
| 2015 FY | -3.32 Million CNY | -104.98% |
| 2014 FY | 66.81 Million CNY | 6.69% |
| 2013 FY | 62.62 Million CNY | 35.46% |
| 2012 FY | 46.23 Million CNY | 0.0% |